Cargando…
Effect-site concentration of propofol required for LMA-Supreme™ insertion with and without remifentanil: a randomized controlled trial
BACKGROUND: A new supraglottic device, the LMA-Supreme™, has recently become available for clinical use. Information on anaesthetic and co-adjuvant requirements for insertion of the LMA-Supreme™ is limited. The present study aimed to evaluate the optimal effect-site concentration of propofol in 50 %...
Autores principales: | Zaballos, Matilde, Bastida, Emilia, Agustí, Salomé, Portas, Maite, Jiménez, Consuelo, López-Gil, Maite |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595052/ https://www.ncbi.nlm.nih.gov/pubmed/26438179 http://dx.doi.org/10.1186/s12871-015-0115-8 |
Ejemplares similares
-
Supreme™ laryngeal mask airway insertion requires a lower concentration of sevoflurane than ProSeal™ laryngeal mask airway insertion during target-controlled remifentanil infusion: a prospective randomised controlled study
por: Monteserín-Matesanz, Cristina, et al.
Publicado: (2020) -
A case of breakage of LMA Supreme(™) on its first use
por: Simon, Binu Puthur
Publicado: (2011) -
Comparison of i-gel® and LMA Supreme® during laparoscopic cholecystectomy
por: Park, Sang Yoong, et al.
Publicado: (2015) -
Effects of Supraglottic Airway Devices on Hemodynamic Response and Optic Nerve Sheath Diameter: Proseal LMA, LMA Supreme, and I-gel LMA
por: Okyay, Rahşan Dilek, et al.
Publicado: (2023) -
Feasibility of LMA Supreme for airway management in unconscious patients by ALS paramedics
por: Länkimäki, Sami, et al.
Publicado: (2015)